English | Español

Biospace
Patient Daily | Mar 16, 2026

Senator Ron Johnson launches investigation into FDA rare disease rejections
Patient Daily | Mar 16, 2026

Dyne Therapeutics reports sustained benefits for Duchenne therapy in long-term study data
Patient Daily | Mar 16, 2026

Stylus Medicine pursues in vivo CAR T cell therapy amid industry shifts
Patient Daily | Mar 16, 2026

Breakout Ventures raises $114 million to support early-stage AI biotech startups
Patient Daily | Mar 16, 2026

Cell and gene therapy manufacturing market projected to reach $146 billion by 2032
Patient Daily | Mar 16, 2026

Nonprofit seeks to modernize drug manufacturing by removing capital barriers
Patient Daily | Mar 16, 2026

FDA outlines scope for meetings to reduce drug approval rejections over manufacturing
Patient Daily | Mar 16, 2026

FDA shift to single pivotal trials raises data and risk management expectations

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures